Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of recombinant human growth hormone with bisphosphonate treatment on bone metabolism in osteogenesis imperfecta
2004-005275-42Phase 4Completed
- Sponsor
- Azienda Ospedaliera Universitaria Integrata Verona
- Start
- Jan 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of somatropin in osteogenesis imperfecta (OI), sponsored by Azienda Ospedaliera Universitaria Integrata Verona. Started Jan 2008; status: completed.
02
Drugs
somatropin
03
Conditions
osteogenesis imperfecta (OI)
Beyond the preview
Go deeper on 2004-005275-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005275-42.